Showing results (771-780 of 882) with videos related to
Sort By:
Pageof 89
Plos One|April 13, 2019
Insights into the genetic diversity of Mycobacterium tuberculosis in TanzaniaLiliana K Rutaihwa, Mohamed Sasamalo, Aladino Jaleco, et al.Frontiers in Integrative Neuroscience|July 25, 2024
Transcutaneous auricular vagus nerve stimulation modulates masseter muscle activity, pain perception, and anxiety levels in university students: a double-blind, randomized, controlled clinical trialLuciano Maia Alves Ferreira, Ricardo Brites, Gonçalo Fraião, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 2, 2022
Efficacy and Safety of Switching to the 2-Drug Regimen Dolutegravir/Lamivudine Versus Continuing a 3- or 4-Drug Regimen for Maintaining Virologic Suppression in Adults Living With Human Immunodeficiency Virus 1 (HIV-1): Week 48 Results From the Phase 3, Noninferiority SALSA Randomized TrialJosep M Llibre, Carlos Brites, Chien-Yu Cheng, et al.The Journal of General Virology|February 5, 2010
Genomic features and evolutionary constraints in Saffold-like cardiovirusesJan Felix Drexler, Sigrid Baumgarte, Luciano Kleber de Souza Luna, et al.The Lancet. Infectious Diseases|February 9, 2019
Dolutegravir versus ritonavir-boosted lopinavir both with dual nucleoside reverse transcriptase inhibitor therapy in adults with HIV-1 infection in whom first-line therapy has failed (DAWNING): an open-label, non-inferiority, phase 3b trialMichael Aboud, Richard Kaplan, Johannes Lombaard, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Distinguishing Secondary Dengue Virus Infection From Zika Virus Infection With Previous Dengue by a Combination of 3 Simple Serological TestsWen-Yang Tsai, Han Ha Youn, Carlos Brites, et al.AIDS and Behavior|September 3, 2024
Patient-Reported Outcomes After Switching to a 2-Drug Regimen of Fixed-Dose Combination Dolutegravir/Lamivudine: 48-Week Results from the SALSA StudyPrincy Kumar, Amanda E Clarke, Celia Jonsson-Oldenbüttel, et al.Virology|September 15, 1999
Molecular epidemiology of human T-cell leukemia virus type I (HTLV-1) Brazil: the predominant HTLV-1s in South America differ from HTLV-ls of Japan and Africa, as well as those of Japanese immigrants and their relatives in BrazilM Yamashita, R Veronesi, M Menna-Barreto, et al.ACS Nano|March 20, 2023
Local Temperature Increments and Induced Cell Death in Intracellular Magnetic HyperthermiaYuanyu Gu, Rafael Piñol, Raquel Moreno-Loshuertos, et al.Journal of Clinical Lipidology|December 12, 2025
Disruption of HDL antioxidant properties in children and adolescents with obesityBelén Davico, Ezequiel Lozano Chiappe, Laura Gaete, et al.Pageof 89